A Study of the Efficacy of Atorvastatin Alone and Its Combination with Omega-3 Fatty Acids in Patients with Hyperlipidemia
Journal Title: Saudi Journal of Medical and Pharmaceutical Sciences - Year 2018, Vol 4, Issue 8
Abstract
Atherosclerosis is one of the major causes of increased morbidity and mortality associated with coronary artery disease, cerebrovascular accidents, and peripheral vascular diseases. Dyslipidemia is one of the important causes that result in atherosclerosis. The incidence of atherosclerosis has been on the rising recently. Therefore prevention of dyslipidemia can decrease the development of atherosclerosis. Aims: The study was undertaken to determine the efficacy of atorvastatin alone and its combination with omega-3 fatty acids in the management of hyperlipidemia in patients attending a tertiary care hospital. Methods: This study was a cross-sectional prospective study conducted in the Department of Pharmacology and General Medicine, Kakatiya Medical College and Hospital, Warangal. The patients were selected from those visiting General Medicine OPD and diagnosed with hyperlipidemia. Sixty patients in the age group of 20 – 70 yrs, were recruited based on inclusion and exclusion criteria. They were divided into two groups. The Group I included the patients receiving Tab. Atorvastatin 10mg/day and Group II Atorvastatin 10mg/day plus Cap Omega-3 fatty acids 600mg/day for the duration of six months and follow up were done every month. Efficacy of treatment was assessed by the changes in laboratory parameters of Total cholesterol, Triglycerides, HDL-C, LDL-C, and VLDL-C. Results: The efficacy of combination therapy i.e., Atorvastatin plus Omega-3 fatty acids showed a statistically significant rise in HDL cholesterol with the mean percentage difference of 4.24% when compared to monotherapy with Atorvastatin. The efficacy of other parameters like total cholesterol (TC), LDL cholesterol, VLDL cholesterol, and triglycerides (TG'S) levels with the low dose of omega-3 fatty acids in combination therapy was not statistically significant and produced nearly identical alterations in serum lipoprotein levels when compared to monotherapy. Conclusion: Although statins are being used as first-line therapy for hyperlipidemia and in patients with elevated triglycerides. For patients with elevated LDL-C and low HDL-C combination therapy appears to be a better option. Thus omega-3 fatty acids may be a potential supplement for combination therapy apart from niacin and fibrates.
Authors and Affiliations
Dr. Madhukar Rao Polasani, Dr. Swathi C
Keywords
Related Articles
- EP ID EP481627
- DOI -
- Views 72
- Downloads 0
Phytochemical Screening, Acute (LD50) and Sub-Chronic Toxicity Studies of Aqueous Stem Bark Extract of CinnamomumVerum
Abstract:Cinnamon has a long history both as a spice and as a medicine. This study was carried out to screen the phytochemicals of the extract as well as to evaluate the acute (LD50) and sub-chronic toxicities of aqueous...
Cost Analysis of Anti- Diabetic Drugs in India
Diabetes is a chronic condition that occurs extremely due to a combination of sedentary lifestyle and following an imbalanced diet. Thus the medications are to be taken for life time. So there is a need for the prescribe...
Perception and Knowledge toward Breast Cancer Prevention and Early Detection: A Comparison between Saudi and Sudanese
The study undertaken the assessment of awareness and specific knowledge, perceived susceptibility, perceived seriousness of breast cancer and perceived benefits of screening for early detection and treatment of women in...
Ameliorative Effect of Menthaspicata on Dichlorvos-Induced Oxidative Stress in the Rat Brain
Abstract:The present study was carried out to evaluate the protective role of aqueous extract of Menthaspicata (MSE) leaf on dichlorvos (DDVP) induced oxidative stress in rat brain. Male rats were divided into 4 groups,...
Silymarin as Herbal Medicine- A Review
Abstract:Silymarin, a flavonolignan contain phenolic and flavanoid component from Silybum marianum plant, is used for the strengthening against various liver conditions in both experimental models and clinical settings....